California pharmaceutical company could acquire Wexford firm

A California-based pharmaceutical company said it had taken the initial steps toward acquiring Wexford-based Coeptis Pharmaceuticals and the exclusive rights to its drug Consensi. Cure Pharmaceutical (OTC: CURE) said Thursday it had bought a $200,000 promissory note issued by Wexford-based Coeptis and had reached a nonbinding term sheet "in furtherance of an acquisition for which the final terms and valuation are to be determined." The promissory note, according to an SEC filing Thursday, is due…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news